Oncaspar 750 UI/ml
Oncaspar 750 UI/ml is a medicine authorised by Swissmedic under authorisation number 66934. The authorisation holder is Servier (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 December 2018 and the authorisation is valid without a time limit. ATC code L01XX24 places the medicine in the group Antineoplastic agents.
| Authorisation number | 66934 |
|---|---|
| Name | Oncaspar 750 UI/ml |
| Full name | Oncaspar 750 UI/ml, poudre pour solution injectable |
| Authorisation holder | Servier (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XX24 |
| First authorisation | 10 December 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Oncaspar 750 UI/ml, poudre pour solution injectable | A | 10 December 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01XX24 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Oncaspar 750 UI/ml authorised in Switzerland?
Yes. Oncaspar 750 UI/ml is authorised by Swissmedic under authorisation number 66934, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Oncaspar 750 UI/ml have?
Oncaspar 750 UI/ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Oncaspar 750 UI/ml?
The authorisation holder is Servier (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.